• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2007 Fiscal Year Final Research Report Summary

Survivin-directed RNA interference is a potent suppressor of leukemia growth

Research Project

Project/Area Number 17590986
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionUniversity of Fukui

Principal Investigator

YOSHIDA Akira  University of Fukui, University of Fukui Hospital, Associate Professor (80252005)

Project Period (FY) 2005 – 2007
KeywordsApoptosis / Survivin-3B / Leukemia / medical treatment
Research Abstract

Survivin, a new member of the inhibitor of apoptosis protein (IAP) family, has been reported to be expressed in cancers. We identified a novel splice variant of survivin, designated as survivin-3B (accession No.AB154416). It comprises 5 exons including novel exon 3B derived from a 165-bp long portion of intron 3. It contains a single bacurovirus IAP repeat (BIR). Expression of survivin-3B was detected in human colon and gastric adenocarcinoma cell lines as well as samples from patients with myelodysplastic syndrome and acute leukemia. However, biological role of survivin-3B remains unclear. We performed experiments to examine its function. Overexpression of survivin-3B in leukemia and colon cancer cells reduced cell death after etoposide and cispla tin treatment, suggesting its anti-apoptotic property. Four types of short h airpin RNAs (shRNAs) (#1#4) were designed, targeting both survivin itself and survivin-3B. The lentivirus-mediated shRNA delivery strongly suppressed H L-60 leukemia growth. These data indicate that survivin-3B possesses anti-apoptotic function. Both survivin-3B and survivin-directed RNA interference is a potent suppressor of leukemia growth.

  • Research Products

    (6 results)

All 2007 2006

All Journal Article (6 results) (of which Peer Reviewed: 3 results)

  • [Journal Article] GP7 induces internucleosomal DNA fragmentation independent of caspase activation and DNA fragmentation factor in NB4 cells.2007

    • Author(s)
      Qi SN, Jing YX, Dong GX, Chen Y, Yoshida A, Ueda T.
    • Journal Title

      Oncol Rep. 18(1)

      Pages: 273-277

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] GP7 induces internucleosomal DNA fragmentation independent of caspase activation and DNA fragmentation factor in NB4 cells2007

    • Author(s)
      Qi, SN, Sing, YX., Dong, GX., Chen, Y., Yoshida, A., Ueda, T
    • Journal Title

      Oncol Rep 18(1)

      Pages: 273-277

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Endonuclease activation and chromosomal DNA fragmentation during apoptosis in leukemia cells.2006

    • Author(s)
      Yoshida A, Pommier Y, Ueda T.
    • Journal Title

      Int J Hematol. 84

      Pages: 31-37

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.2006

    • Author(s)
      Yoshida A^*, Takemura H, Inoue H, Miyashita T, Ueda T.
    • Journal Title

      Cancer Res. 66

      Pages: 5772-5780

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Endonuclease activation and chromosomal DNA fragmentation during apoptosis In leukemia cells2006

    • Author(s)
      Yoshida, A., Pozmnier, Y., Ueda, T
    • Journal Title

      Int J Hematol 84

      Pages: 31-37

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death viamitochondrial-independent pathway2006

    • Author(s)
      Yoshida, A*., Takemura, H., Inoue, H., Miyashita, T., Ueda, T
    • Journal Title

      Cancer Res 66

      Pages: 5772-5780

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2010-02-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi